Geode Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.8M | Buy |
2,416,197
+96,818
| +4% | +$439K | ﹤0.01% | 2364 |
|
|
2026
Q1 | $10.4M | Buy |
2,319,379
+88,087
| +4% | +$459K | ﹤0.01% | 2364 |
|
|
2025
Q4 | $13.7M | Buy |
2,231,292
+6,123
| +0.3% | +$44.4K | ﹤0.01% | 2227 |
|
|
2025
Q3 | $16.1M | Buy |
2,225,169
+2,207
| +0.1% | +$13.1K | ﹤0.01% | 2117 |
|
|
2025
Q2 | $11.8M | Sell |
2,222,962
-7,804
| -0.3% | -$46.1K | ﹤0.01% | 2252 |
|
|
2025
Q1 | $19.8M | Buy |
2,230,766
+87,897
| +4% | +$1.06M | ﹤0.01% | 1910 |
|
|
2024
Q4 | $29.4M | Sell |
2,142,869
-11,166
| -0.5% | -$206K | ﹤0.01% | 1747 |
|
|
2024
Q3 | $59M | Buy |
2,154,035
+21,220
| +1% | +$574K | ﹤0.01% | 1318 |
|
|
2024
Q2 | $52.2M | Buy |
2,132,815
+116,443
| +6% | +$2.55M | ﹤0.01% | 1335 |
|
|
2024
Q1 | $43M | Buy |
2,016,372
+144,515
| +8% | +$3.11M | ﹤0.01% | 1456 |
|
|
2023
Q4 | $35.8M | Buy |
1,871,857
+144,973
| +8% | +$2.51M | ﹤0.01% | 1548 |
|
|
2023
Q3 | $27.7M | Buy |
1,726,884
+62,037
| +4% | +$1.18M | ﹤0.01% | 1615 |
|
|
2023
Q2 | $38.6M | Buy |
1,664,847
+60,740
| +4% | +$1.33M | ﹤0.01% | 1421 |
|
|
2023
Q1 | $37.3M | Buy |
1,604,107
+78,333
| +5% | +$1.59M | ﹤0.01% | 1390 |
|
|
2022
Q4 | $22.1M | Buy |
1,525,774
+55,004
| +4% | +$1.02M | ﹤0.01% | 1707 |
|
|
2022
Q3 | $28.1M | Buy |
1,470,770
+25,478
| +2% | +$585K | ﹤0.01% | 1508 |
|
|
2022
Q2 | $26.3M | Sell |
1,445,292
-2,665
| -0.2% | -$55.3K | ﹤0.01% | 1560 |
|
|
2022
Q1 | $36.5M | Buy |
1,447,957
+18,879
| +1% | +$483K | ﹤0.01% | 1473 |
|
|
2021
Q4 | $39.4M | Buy |
1,429,078
+49,362
| +4% | +$1.43M | ﹤0.01% | 1481 |
|
|
2021
Q3 | $44.6M | Buy |
1,379,716
+15,951
| +1% | +$530K | 0.01% | 1379 |
|
|
2021
Q2 | $41.7M | Buy |
1,363,765
+100,088
| +8% | +$2.89M | 0.01% | 1466 |
|
|
2021
Q1 | $38.5M | Buy |
1,263,677
+119,711
| +10% | +$3.4M | 0.01% | 1438 |
|
|
2020
Q4 | $22.6M | Buy |
1,143,966
+21,092
| +2% | +$341K | ﹤0.01% | 1645 |
|
|
2020
Q3 | $14.6M | Sell |
1,122,874
-22,827
| -2% | -$289K | ﹤0.01% | 1737 |
|
|
2020
Q2 | $13M | Buy |
1,145,701
+41,075
| +4% | +$583K | ﹤0.01% | 1776 |
|
|
2020
Q1 | $15.8M | Buy |
1,104,626
+51,073
| +5% | +$1.08M | ﹤0.01% | 1458 |
|
|
2019
Q4 | $28.7M | Buy |
1,053,553
+43,571
| +4% | +$1.2M | 0.01% | 1323 |
|
|
2019
Q3 | $28.9M | Buy |
1,009,982
+11,539
| +1% | +$336K | 0.01% | 1233 |
|
|
2019
Q2 | $27.7M | Buy |
998,443
+71,670
| +8% | +$2.02M | 0.01% | 1253 |
|
|
2019
Q1 | $30.8M | Buy |
926,773
+47,324
| +5% | +$1.44M | 0.01% | 1120 |
|
|
2018
Q4 | $25.6M | Buy |
879,449
+103,528
| +13% | +$3.72M | 0.01% | 1109 |
|
|
2018
Q3 | $35.7M | Buy |
775,921
+42,900
| +6% | +$1.91M | 0.01% | 1011 |
|
|
2018
Q2 | $27.4M | Buy |
733,021
+56,762
| +8% | +$1.92M | 0.01% | 1120 |
|
|
2018
Q1 | $20M | Buy |
676,259
+59,463
| +10% | +$2.01M | 0.01% | 1263 |
|
|
2017
Q4 | $21.2M | Sell |
616,796
-42,631
| -6% | -$1.44M | 0.01% | 1233 |
|
|
2017
Q3 | $23.9M | Buy |
659,427
+5,552
| +0.8% | +$158K | 0.01% | 1110 |
|
|
2017
Q2 | $16.9M | Sell |
653,875
-7,432
| -1% | -$158K | 0.01% | 1319 |
|
|
2017
Q1 | $12.7M | Buy |
661,307
+19,251
| +3% | +$341K | 0.01% | 1467 |
|
|
2016
Q4 | $10.7M | Buy |
642,056
+18,428
| +3% | +$333K | 0.01% | 1518 |
|
|
2016
Q3 | $12.8M | Buy |
623,628
+62,600
| +11% | +$1.59M | 0.01% | 1324 |
|
|
2016
Q2 | $17.2M | Buy |
561,028
+33,436
| +6% | +$1.16M | 0.01% | 1048 |
|
|
2016
Q1 | $19.7M | Buy |
527,592
+37,842
| +8% | +$1.43M | 0.01% | 939 |
|
|
2015
Q4 | $21.1M | Buy |
489,750
+7,092
| +1% | +$300K | 0.01% | 862 |
|
|
2015
Q3 | $18.1M | Buy |
482,658
+26,589
| +6% | +$944K | 0.01% | 943 |
|
|
2015
Q2 | $15.5M | Buy |
456,069
+54,590
| +14% | +$1.86M | 0.01% | 1101 |
|
|
2015
Q1 | $14.2M | Buy |
401,479
+8,167
| +2% | +$292K | 0.01% | 1123 |
|
|
2014
Q4 | $13.4M | Buy |
393,312
+5,482
| +1% | +$195K | 0.01% | 1105 |
|
|
2014
Q3 | $15M | Buy |
387,830
+3,425
| +0.9% | +$128K | 0.01% | 1004 |
|
|
2014
Q2 | $15M | Buy |
384,405
+9,858
| +3% | +$367K | 0.01% | 1006 |
|
|
2014
Q1 | $12.8M | Sell |
374,547
-1,413
| -0.4% | -$43.8K | 0.01% | 1077 |
|
|
2013
Q4 | $7.89M | Sell |
375,960
-116,346
| -24% | -$2.94M | 0.01% | 1370 |
|
|
2013
Q3 | $11.6M | Buy |
492,306
+32,335
| +7% | +$919K | 0.01% | 974 |
|
|
2013
Q2 | $12.4M | Buy |
+459,971
| New | +$13.3M | 0.01% | 839 |
|
Other funds holding MYGN
VPC
Geode Capital Management's MYGN Position: Q2 2026 in Review
Geode Capital Management increased its Myriad Genetics (MYGN) stake by 4.2% in Q2 2026, buying an estimated $439K and bringing the position to 2,416,197 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2364.
Geode Capital Management first reported a position in MYGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $59M in Q3 2024. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Geode Capital Management held 2,416,197 shares of Myriad Genetics worth $13.8M as of Q2 2026.
- Geode Capital Management bought 96,818 Myriad Genetics shares in Q2 2026, an estimated $439K.
- Myriad Genetics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2364 holding.
- Geode Capital Management first reported a position in Myriad Genetics in Q2 2013 and has held it in 53 quarters since.
- Geode Capital Management's Myriad Genetics position peaked at $59M in Q3 2024.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.